🚀NASA's Exclusive Patent License Notice Impacting QuakeLogic
NASA hereby gives notice of its intent to grant an exclusive, co-exclusive or partially exclusive patent license to practice the inventions described and claimed in the patents and/or patent applications listed in SUPPLEMENTARY INFORMATION below.
Learn More💊Exclusive Patent License Notice for CAR Technology by NIH
The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patents applications listed in the Supplementary Information section of this notice to Capstan Therapeutics, Inc. (Capstan), a company located in San Diego, California, the United States of America.
Learn More🛠️Notice of Intent to Grant Exclusive Patent License to ColdQuanta
Pursuant to the Bayh-Dole Act and implementing regulations, the Department of the Air Force hereby gives notice of its intent to grant an exclusive patent license to ColdQuanta, Inc., a Delaware corporation dba Infleqtion, having a place of business at 3030 Sterling Cir., Boulder, CO 80301-2338.
Learn More🛠️NASA's Intent to Grant Exclusive Patent Licenses
NASA hereby gives notice of its intent to grant an exclusive, co-exclusive or partially exclusive patent license to practice the inventions described and claimed in the patents and/or patent applications listed in SUPPLEMENTARY INFORMATION below.
Learn More💡NIH Licensing Opportunities for Novel Tissue Oximeter Technology
The National Institute of Child Health and Human Development (NICHD), an institute of the National Institutes of Health (NIH), Department of Health and Human Services (HHS), is giving notice of the licensing or collaboration opportunities for the inventions listed below, which are owned by an agency of the U.S. Government and are available for licensing and collaboration to achieve expeditious commercialization of results of federally-funded research and development.
Learn More🧬Exclusive Patent License Opportunity for Biomedical Innovations
The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable patent license to Cambridge Enterprise Limited, University of Cambridge, located in Cambridge, United Kingdom, to practice the inventions embodied in the patent applications listed in the Supplementary Information section of this notice.
Learn More💰NIH Notice of Closed Meetings for Small Business Grant Evaluations
The Department of Health and Human Services announces closed meetings of the National Center for Advancing Translational Sciences to review grant applications for small business innovation and technology transfer. The meetings will be held on April 8-9 and April 10-11, 2025, focusing on confidential evaluations crucial for advancing health research funding.
Learn More🔍NSF Seeks Comments on Proposed Intellectual Property Options
On December 12, 2024, the National Science Foundation (NSF) published in the Federal Register a document entitled "Request for Comments on NSF's Proposed Intellectual Property Options." In response to requests by prospective commenters that they would benefit from additional time to adequately consider and respond to the RFC, NSF has determined that an extension of the comment period until Friday, February 21, 2025, at 11:59 p.m. (eastern), is appropriate. NSF also is adding language to clarify the intent for intellectual property options.
Learn More